Australia Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Australia Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027


Summary

Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Australian pharmaceuticals market had total revenues of $10.5 billion in 2022, representing a negative compound annual growth rate (CAGR) of 1.4% between 2017 and 2022.
  • 0
  • R&D expenditure in Australia is only 1.8% of GDP, below the OECD average of 2.67%. Government spending on R&D has been declining, with an average of 0.61% since 2010-11.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Australia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the Australia pharmaceuticals market by value in 2022?
  • What will be the size of the Australia pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the Australia pharmaceuticals market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Australia's pharmaceuticals market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Pfizer Inc.
8.2. Aspen Pharmacare Holdings Ltd
8.3. GSK plc.
8.4. AstraZeneca PLC
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Australia pharmaceuticals market value: $ billion, 2017-22
Table 2: Australia pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Australia pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Pfizer Inc.: key facts
Table 5: Pfizer Inc.: Annual Financial Ratios
Table 6: Pfizer Inc.: Key Employees
Table 7: Pfizer Inc.: Key Employees Continued
Table 8: Aspen Pharmacare Holdings Ltd: key facts
Table 9: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 10: Aspen Pharmacare Holdings Ltd: Key Employees
Table 11: GSK plc.: key facts
Table 12: GSK plc.: Annual Financial Ratios
Table 13: GSK plc.: Key Employees
Table 14: GSK plc.: Key Employees Continued
Table 15: AstraZeneca PLC: key facts
Table 16: AstraZeneca PLC: Annual Financial Ratios
Table 17: AstraZeneca PLC: Key Employees
Table 18: AstraZeneca PLC: Key Employees Continued
Table 19: Australia size of population (million), 2018-22
Table 20: Australia gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Australia gdp (current prices, $ billion), 2018-22
Table 22: Australia inflation, 2018-22
Table 23: Australia consumer price index (absolute), 2018-22
Table 24: Australia exchange rate, 2018-22
List of Figures
Figure 1: Australia pharmaceuticals market value: $ billion, 2017-22
Figure 2: Australia pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Australia pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Australia, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Australia, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Australia, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings